In light of recent developments, the editorial team wishes to address the matter of competing interests associated with the published animal study on the use of drug X for the treatment of clinical condition A.
Upon thorough examination and in accordance with the Committee on Publication Ethics (COPE) guidelines, it was determined that the corresponding author failed to declare a potential competing interest. The author, who holds patents on drug X and is listed as an inventor, did not disclose this information during the initial submission process.
In response to these findings, a correction was prepared to acknowledge the competing interest, as suggested by COPE. However, it was observed that the reference to the authors' affiliation with a non-profit institute, while factually accurate, was not directly relevant to the potential competing interests at hand.
After careful consideration and communication with the corresponding author, it was proposed to publish a correction that clearly articulates the nature of the undisclosed competing interest. The suggested correction was intended to provide transparency and ensure that readers can make informed assessments of the paper's conclusions.
Regrettably, the corresponding author expressed reservations about a declaration that did not specifically mention the "non-profit" status of the institution. Despite clarifications on the relevance of this detail and the ethical necessity to disclose potential competing interests, the author declined to consent to a correction without the inclusion of the term "non-profit."
The editorial team acknowledges the importance of transparent communication and wishes to assure the readership that efforts have been made to address this matter in accordance with established ethical guidelines. We appreciate the ongoing dialogue and input from the corresponding author and will continue to adhere to principles that uphold the integrity of scholarly publishing.
It is essential to note that the commitment to transparency and declaration of competing interests remains a cornerstone of ethical publishing practices. The editorial team values the input of the academic community and will consider constructive suggestions for enhancing the clarity of our conflict of interest policy.